Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-000030-11Phase 3Completed
Phase 3 trial of acetylcysteine in hepatic disease (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoints: Total bilirubin, Primary graft dysfunction and 6 more. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-000030-11.